The First Vaccination Application in the World Against the MonkeyPox Epidemic Is Starting: The USA Has Become the First Country

The US Centers for Disease Control and Prevention has announced that work has begun on the use of a vaccine against the monkeypox virus in the country. The vaccine is planned to be used in ‘high-risk’ contacts.

The monkeypox virus, which has created fears of a new outbreak in the world after the coronavirus, has been seen in 16 different countries so far. Especially in Western Europe, cases continue to increase, while US President Joe Biden’s statement that “Everyone should be concerned” also increased attention to the virus.

Today, there has been an extremely significant development in the USA about the monkeypox virus. The U.S. Centers for Disease Control and Prevention (CDC) announced that the monkeypox vaccine in the country’s Strategic National Stockpile against the monkeypox virus, which has been increasing in the country, will be put into use.

The Jynneos vaccine will be used in high-risk patients

Dr. from CDC In a statement shared by Jennifer McQuiston, “I can inform you that there is a demand for the release of the Jynneos vaccine from the National Stock for high-risk contacts of some of the first patients, it is currently actively taking place.” he used his statements. McQuiston explained that the United States also has a good stockpile of vaccines, as it prepares for the possibility of the need to use doses for smallpox.

The Jynneos vaccine in question was licensed in the United States to prevent smallpox and especially monkeypox. According to the information transmitted by McQuiston, the country currently has more than 1,000 doses, and the company has already begun to provide more doses to the United States. Another licensed vaccine that can be used to prevent monkeypox, ACAM2000, has been announced to have more than 100 million doses in the country.